SRDX:
Analysis & Opinions
-
January 11, 2013
On January 10, we upgraded blood management solutions, Haemonetics Corporation (HAE) to Outperform based on its huge ...
-
January 11, 2013
On January 10, Zacks Investment Research upgraded SurModics, Inc. (SRDX) to a Zacks Rank #1 (Strong Buy). Why the ...
-
December 28, 2012
SurModics, Inc. (SRDX), a provider of surface modification and drug delivery technologies to the healthcare ...
-
November 21, 2012
We are reverting to a Neutral recommendation on SurModics Inc. (SRDX) from Outperform as we believe that the stock ...
-
November 08, 2012
SurModics Inc.'s (SRDX) fourth quarter fiscal 2012 earnings (excluding special items) of 19 cents per share beat the ...
-
October 05, 2012
Shares of SurModics Inc. (SRDX) have been on an upswing since reporting a solid fiscal third quarter in early ...
-
August 21, 2012
We recently upgraded SurModics Inc. (SRDX) to Outperform from Neutral following its impressive results in the third ...
-
August 09, 2012
SurModics Inc. (SRDX) has delivered four positive earnings surprises in the last five quarters, and its shares have ...
-
August 03, 2012
SurModics Inc.'s (SRDX) third quarter fiscal 2012 earnings from continued operations (excluding special items) of 17 ...
